Highlights

In France :

  • The plan to merge the preparation and distribution laboratories, announced in 2008, was implemented with the closure of the Metz facility in January, Amiens in March and the merging of the two laboratories in Nantes in January, and those in Bordeaux in April.
  • Since January 1st, 2009, the Montevrain team and production plant have became part of Boiron SA.
  • June 5th, 2009 distribution of a dividend of €0.60 per share in respect of 2008 earnings
  • Boiron bought back 251,972 shares within the framework of the share buyback program.

Abroad :

  • Since May 2009, the Euphralia® eyewash has been marketing in Spain.
  • Since May 7th, 2009, the Group has been marketing Oscillococcinum® in Brazil. In this regard, a BRL 1,400,000 capital increase took place at Boiron Brazil, the June, 2009.
  • In March 2009, the Brazilian subsidiary has obtained registration of Sédatif PC®.
  • April 2009, increase of shareholder’s equity in Switzerland.
  • May 14, 2009, decision to establish a subsidiary in Portugal.
  • In January 2009, UNDA and Boiron SA paid to a trading partner in compensation €3,400 thousand, a provision was booked in December 31st, 2008.